SENSEX NIFTY

Religare Capital Markets

Dec 19, 2014 at 11:28 | Source: CNBC-TV18
Prakash Diwan believes the market has already priced in the fact that the government may miss its fiscal deficit target of 4.1 percent. He believes valuations are still stretched despite the recent correction and there is still a chance of a 4-5% softness ahead, particularly on the mid-cap side.
Dec 19, 2014 at 10:58 | Source: Moneycontrol.com
Equity Mutual Funds advance as Short covering-led buying interest in stocks post Fed meet outcome helped the Sensex snap five-day losing streak on Thursday.
Dec 18, 2014 at 21:16 | Source: CNBC-TV18
Crowdfunding is being used not only to raise funds for causes like art exhibitions, but also for CSR activities by NGOs. Market experts say this phenomenon should be assimilated into capital markets.
Dec 18, 2014 at 17:11 | Source: Moneycontrol.com
Monte Carlo Fashions is going to list its equity shares on the Bombay Stock Exchange and National Stock Exchange (Capital Market segment) on December 19, 2014.
Dec 18, 2014 at 09:22 | Source: CNBC-TV18
Watch the interview of Manoj Murlidharan of Religare Securities with Latha Venkatesh & Reema Tendulkar on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
Dec 17, 2014 at 15:38 | Source: CNBC-TV18
Manish Singh of Crossbridge Capital LLP believes soft energy prices are a big positive for emerging markets and one should buy into these markets with a 6-12 month perspective.
Dec 17, 2014 at 15:16 | Source: CNBC-TV18
Watch the interview of Manish Hathiramani of Deen Dayal Investments with Reema Tendulkar & Ekta Batra on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
Dec 17, 2014 at 10:14 | Source: Moneycontrol.com
Returns given by equity investments decide the returns investors get over and above return of capital. Investors can expect returns in excess of fixed deposits from such schemes
Dec 16, 2014 at 20:11 | Source: CNBC-TV18
The currency market is not spooked by the Russian central bank move, which raised its key interest rate from 10.5% to 17%, resulting in the Russian rouble falling to 71/USD, but it is the unpredictability with respect to the rouble versus the dollar scenario that is also leading to rupee's fall, says Sanju Verma
Dec 16, 2014 at 10:04 | Source: Moneycontrol.com
Equity Mutual Funds ended in red as the markets consolidate on Monday, the first day of the week on a flat note despite sharp fall in November WPI inflation and weak rupee.
Messages on Religare Capital Markets »

Web Messenger

Platinum Member

257738 Followers

Indian indices  

Source:NDTV Profit - 2:30 p.m. Tirthankar Patnaik of Religare Capital Markets says that Nifty has could run up by another 100-150 points before the fundamentals catch up. (Track stocks). All the sectoral indices, except the pharma, are trading higher. Gail India, Tech

4.55 PM Mar 6th

cleverman

Platinum Member

92 Followers

Ranbaxy Labs  

also the stock will have a downside of around 10-15 per cent from these levels. We recommend a sell on the stock," adds Nangra. Arvind Bothra, Vice President, institutional research, Religare Capital Markets, says, "we expect significant negative impact on stock price following this news and reiterate

8.15 PM Jan 24th

BSE/NSE Announcer

Platinum Member

5576 Followers

Crompton Greave  

"). This Advertisement should be read in conjunction with, and in continuation of, the Public Announcement (PA") published on July 04, 2013 and corrigenda to the PA published on July 16, 2013 and November 09,2013 to the shareholders of Crompton Greaves Limited ("Target Company")Religare Capital Markets Ltd

5.45 PM Jan 16th

Web Messenger

Platinum Member

257738 Followers

Ipca Labs  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

257738 Followers

Glenmark  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on pharma space. ET Now: On the entire pharma space, do you think that can still continue to be the big bet into 2014 given

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

257738 Followers

News Now  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on market movement in 2014. ET Now: Last day of 2013, how does that really set stage for what your outlook is in the initial part

3.29 PM Dec 31st 2013

Web Messenger

Platinum Member

257738 Followers

Infosys  

Source:Economic Times - In a chat with ET Now, Dr Tirthankar Patnaik, Director, Strategist-Institutional Research, Religare Capital Markets Limited, shares his views on Infosys. ET Now: What makes you bullish on Infosys? Dr Tirthankar Patnaik: We are positive on the whole IT sector and therefore

3.25 PM Dec 31st 2013

DLF  

The central bank will hike repo rate, or the rate at which banks borrow from the central bank (Reserve Bank of India), by a total of 50 basis points (bps) till FY14-end, believes Tirthankar Patnaik, executive vice president- institutional sales, Religare Capital Markets. So it will sock to real

11.52 AM Oct 25th 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.47 PM Oct 23rd 2013

Infosys  

IT space good buy, Infosys and Tech Mahindra top picks: Gautam Trivedi, MD & Head of Equities, Religare Capital Markets Ltd

2.46 PM Oct 23rd 2013

News across the web »
Jul 08, 2014 at 07:59 | Source: FirstPost